FindTrial
Sign In

Study on Clinical Features, Expression of miRNA and Inflammatory Factors in Type 2 Cardiorenal Syndrome

Heart kidney homologous thoughts based on microRNA regulating chain in pathogenesis of type 2 cardiorenal syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016505
Enrollment
Unknown
Registered
2018-06-05
Start date
2018-06-05
Completion date
Unknown
Last updated
2018-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic heart failure, type 2 cardiolrenal syndrome

Interventions

Type 2 Cardio Renal Syndrume:Nil
Chronic Heart Failure group:Nil

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of chronic heart failure; 2. Meet the diagnostic criteria of Yang-deficiency syndrome; 3. The cardio-renal syndrome group meet the diagnostic criteria for type 2 CRS on the basis of the criteria mentioned above; 4. sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Heart failure caused by valvular heart disease, congenital heart disease, myocarditis and cardiomyopathy; 2. History of kidney disease; 3. Severe liver disease or endocrine disease; 4. Mental disordered that could not sign the informed consent

Design outcomes

Primary

MeasureTime frame
microRNA;—

Secondary

MeasureTime frame
NF-kB mRNA;TLR4-mRNA;IL-1ß;IL-6;IL-18;TNF-a;NF-kB;TLR4;Creatine;eGFR;—

Countries

China

Contacts

Public ContactSong Qingqiao

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

sqqbj@139.com+86 13911873540

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026